Jan-Erik has 30+ years of experience from Astra Zeneca in several leading position. His expertise includes drug discovery and projects. Expert in intellectual property both as inventor and as chairman of a company patent committee.

Anna-Lena has 25+ years in immunology research, With previous experiences from Karolinska Institutet, Institut Pasteur, and Dana-Farber Cancer Institute, Harvard Medical School. Previous SME experiences as a project leader, co-founder and board member in Avaris AB (2001-2012)

Mona is CEO of SU Holding and has a scientific background in Biochemistry and Immunology. Previous experiences in leadership positions in SMEs since 1985. Engagement in investment management and business development of SMEs since 2007.

John is a former entrepreneur, having successfully founded and sold 2 of his companies. Experienced life science investor with an academic background in medical chemistry. Represents an investor team with a collective 100+ investments.

Pirkko Tamsen is a highly accomplished professional with an impressive track record of over 30 years in the pharmaceutical industry. She has held various leadership positions, including CEO of several small pharmaceutical companies and CRO firms, as well as positions in prominent pharmaceutical companies like Astra and Kabi. Pirkko has previously been part of the Board of Directors at Karolinska Institutet Innovations AB, Alzecure Pharma AB and Örebro University Holding AB.

Peder is a licensed physician and economist, currently active as an investor and advisor in the life science sector, and a board member of Immedica Pharma AB. Walberg has a long-standing career in life science, with extensive experience in drug development and commercialization—including leading the Swedish launch of Elidel for atopic dermatitis during his time at Novartis. He has played a central role in strategic decision-making, regulatory planning, and negotiations with licensing partners and acquirers. His previous roles include key positions at Sobi, Wilson Therapeutics, Immedica Pharma AB, and Egetis Therapeutics.

Christian is Investment Manager at Almi Invest, where he focuses on identifying and supporting promising companies in the life science sector. With a background in medicinal chemistry, he combines a strong scientific foundation with extensive experience in business development and research commercialization. He previously led the DRIVE incubator at KI Innovations, where he coached several successful startups. He is also an inventor with multiple patents and co-founder and leader in several biotech companies, moving drug candidates into clinical trials.